MiMedx Group, Inc. MDXG

Set alert

Price alert · MDXG

All alert types
3.28 USD -0.60 -15.46%

At close

3.01 -0.27 -8.23%

Pre-market · Nov 3, 5:50 AM ET

Bid
3.27 × 1
Ask
3.28 × 5
3.27 Day range 3.88
3.03 52-week range 7.97
YTD
-51.55%
1 year
-56.38%
Open
3.88
Prev close
3.88
Mkt cap
478.64M
Vol
2.56M
Avg vol
1.29M
EPS
-0.13
P/E
0.00
Div yield
0.00%
More statistics
Low
3.27
High
3.88
Forward P/E
21.65
Beta
1.73
Short ratio
11.09
Inst. own
71.52%
Dividend
0.00
Ex-div date
Earnings
Feb 25, 2026
50-d avg
7.05
200-d avg
7.43
1y target
12.20

MAX chart

Chart tools
Interval

Events in this range
  • Apr 2, 2008Split: 0.324 for 1
  • Jul 2, 2024Rating: Cantor Fitzgerald · — → Overweight
  • Aug 1, 2024Rating: Craig-Hallum · Buy → Buy
  • Aug 1, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
Signals (75)
NameDateAgo
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishNov 1, 20251 year ago
SMA: BearishNov 1, 20251 year ago
SMA: BullishOct 1, 20251 year ago
SMA: BullishOct 1, 20251 year ago
SMA: BearishAug 1, 20251 year ago
SMA: BullishJul 1, 20251 year ago
SMA: BearishMay 1, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
SMA: BearishMar 1, 20251 year ago
SMA: BullishNov 1, 20242 years ago
MACD: Buy SignalNov 1, 20242 years ago
MACD: Sell SignalSep 1, 20242 years ago
SMA: BearishAug 1, 20242 years ago
SMA: BullishJul 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishJun 1, 20233 years ago
SMA: BullishApr 1, 20233 years ago
MACD: Buy SignalApr 1, 20233 years ago

Newest 20 of 75.

Analyst view

Consensus: none

Price target (mean) 12.20 +272.0% upside
Target (low)
12.00
Target (mean)
12.20
Target (high)
13.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MDXG analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.0750.07 – 0.080.07+7.1%94.73M+12.7%2
Next quarter0.0850.08 – 0.090.07+21.4%104.97M+13.0%2
Current year0.3250.32 – 0.330.29+12.1%386.53M+10.8%2
Next year0.350.34 – 0.360.325+7.7%418.56M+8.3%2

Upgrades and downgrades

The latest rating changes

MDXG analyst upgrades and downgrades
DateFirmActionFromTo
Jul 31, 2025Cantor FitzgeraldMaintainedOverweightOverweight
Jul 15, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Feb 27, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Aug 1, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 1, 2024Craig-HallumMaintainedBuyBuy
Jul 2, 2024Cantor FitzgeraldInitiated—Overweight
May 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 7, 2024Lake StreetInitiated—Buy
Mar 1, 2024MizuhoMaintainedBuyBuy
Oct 31, 2023MizuhoMaintainedBuyBuy
Oct 27, 2023Craig-HallumInitiated—Buy
Aug 2, 2023MizuhoMaintainedBuyBuy
Aug 2, 2023HC Wainwright & Co.MaintainedBuyBuy
Jun 21, 2023HC Wainwright & Co.MaintainedBuyBuy
May 3, 2023HC Wainwright & Co.Maintained—Buy
Mar 2, 2023HC Wainwright & Co.Reiterated—Buy
Oct 13, 2022MizuhoInitiated—Buy
Sep 7, 2022HC Wainwright & Co.Maintained—Buy
Sep 14, 2021HC Wainwright & Co.Maintained—Buy
Jul 26, 2021Northland Capital MarketsInitiated—Outperform
Mar 19, 2021HC Wainwright & Co.Initiated—Buy
Feb 26, 2018Lake StreetDowngradeBuyHold
Feb 20, 2018NeedhamDowngradeStrong BuyHold
May 23, 2017First AnalysisDowngradeEqual-WeightUnderweight
Mar 3, 2017Piper SandlerInitiated—Overweight
Dec 12, 2016UBSInitiated—Sell
Nov 8, 2016Aegis CapitalInitiated—Buy
Apr 19, 2016Lake StreetMaintained—Buy
Nov 16, 2015NeedhamUpgradeBuyStrong Buy
Oct 30, 2015Northland Capital MarketsUpgradeMarket PerformOutperform